Rutgers Institute for Health researchers analyze subgroups of women and how their substance-use patterns and personal characteristics correlate to how they have been impacted by COVID-19.
Tobias Gerhard, interim director of Rutgers Institute for Health, Health Care Policy and Aging Research and founding director of Rutgers Center for Pharmacoepidemiology and Treatment Science, has been named president of the International Society for Pharmacoepidemiology (ISPE).
Rutgers researchers will conduct the largest and most comprehensive study of children at high risk of developing a life-threatening complication of Type 1 diabetes with funding from JDRF.
Rutgers Center for State Health Policy launched the New Jersey Integrated Population Health Data (iPHD) Project this week to address some of the state’s most pressing health care issues with a virtual Research Consortium.
New research finds people who were using buprenorphine obtained without a prescription were more likely to remain in treatment for opioid-use disorder, underscoring need to expand access to this medication.
Rutgers researchers are calling for a change in our approach to developing COVID-19 vaccines, and vaccines to fight future pandemics, to incorporate both conventional and challenge trails.
According to a new study, primary care physicians and nurse practitioners who participated in a Rutgers Project ECHO complex endocrinology tele-mentoring program at Robert Wood Johnson Medical School (RWJMS) improved care for patients with diabetes.
Rutgers researchers examined how often youth who overdosed on a benzodiazepine or stimulant had a recent medical prescription for that drug.
While many people skipped regular health check-ups during the COVID-19 pandemic, new research indicates that people with multiple sclerosis (MS) used online telehealth services more frequently to keep in contact with their health care providers and were highly satisfied with the outcome.
According to a Rutgers study, if all countries adopted the same tax on carbon emissions and returned the revenues to their citizens, it is possible to keep the global temperature from rising more than 2 degrees Celsius while also benefiting wellbeing, reducing inequality, and alleviating poverty.
Rutgers Institute for Health, Health Care Policy and Aging Research, in close collaboration with New York University, has received $11.6 million in funding from the National Institute on Minority Health and Health Disparities to develop the Rutgers-NYU Center for Asian Health Promotion and Equity (CAHPE).
New report published in Drug and Alcohol Dependence demonstrates how phone sensor data, such as GPS, can be used to detect cannabis intoxication in young adults.
The Rutgers Institute for Health, Health Care Policy and Aging Research has received $10 million in funding from the Robert Wood Johnson Foundation and Rutgers University to support the New Jersey Population Health Cohort study – the largest study to date to explore factors that influence health and well-being in New Jersey.
Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms. Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health, Health Care Policy and Aging Research, discusses the future of precision medicine, what needs to be done to successfully analyze the data necessary to develop individualized treatments and the role genetics play during the COVID-19 pandemic.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
